Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305361200 on June 16, 2003

J. Biol. Chem., Vol. 278, Issue 35, 32852-32860, August 29, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/35/32852    most recent
M305361200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbier, O.
Right arrow Articles by Staels, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbier, O.
Right arrow Articles by Staels, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Peroxisome Proliferator-activated Receptor {alpha} Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme*

Olivier Barbier {ddagger}, Daniel Duran-Sandoval {ddagger}, Inés Pineda-Torra {ddagger}, Vladimir Kosykh §, Jean-Charles Fruchart {ddagger} and Bart Staels {ddagger} ¶

From the {ddagger}Unité de Recherche 545, Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'Athérosclérose, Institut Pasteur de Lille and the Faculté de Pharmacie, Université de Lille II, 59019 Lille, France and §Institute of Experimental Cardiology, Russian Cardiology Complex, Moscow 121552, Russia

Glucuronidation, a major metabolic pathway for a large variety of endobiotics and xenobiotics, is catalyzed by enzymes belonging to the UDP-glucuronosyltransferase (UGT) family. Among UGT enzymes, UGT2B4 conjugates a large variety of endogenous and exogenous molecules and is considered to be the major bile acid conjugating UGT enzyme in human liver. In the present study, we identify UGT2B4 as a novel target gene of the nuclear receptor peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}), which mediates the hypolipidemic action of fibrates. Incubation of human hepatocytes or hepatoblastoma HepG2 and Huh7 cells with synthetic PPAR{alpha} agonists, fenofibric acid, or Wy 14643 resulted in an increase of UGT2B4 mRNA levels. Furthermore, treatment of HepG2 cells with Wy 14643 induced the glucuronidation of hyodeoxycholic acid, a specific bile acid UGT2B4 substrate. Analysis of UGT2B mRNA and protein levels in PPAR{alpha} wild type and null mice revealed that PPAR{alpha} regulates both basal and fibrate-induced expression of these enzymes in rodents also. Finally, a PPAR response element was identified in the UGT2B4 promoter by site-directed mutagenesis and electromobility shift assays. These results demonstrate that PPAR{alpha} agonists may control the catabolism of cytotoxic bile acids and reinforce recent data indicating that PPAR{alpha}, which has been largely implicated in the control of lipid and cholesterol metabolism, is also an important modulator of the metabolism of endobiotics and xenobiotics in human hepatocytes.


Received for publication, May 22, 2003

* This work was supported by grants from the Fondation Lefoulon-Delalande, Institut de France (to O. B.), the European community (ERBFMBICT983214) (to I. P.-T.), the ministerio de Hacienda del Gobierno de Chile (to D. D.-S.), the Fonds Européens de Développement Régional, Conseil Régional Région Nord/Pas-de-Calais (Genopole Project Grant 01360124), and the Leducq Foundation (to B. S. and J.-C. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Unité INSERM 545, Institut Pasteur de Lille, 1, rue du Pr Calmette, BP 245, 59019 Lille, France. Tel.: 33-3-20-87-73-87; Fax: 33-3-20-87-71-98; E-mail: bart.staels{at}pasteur-lille.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
D. B. Buckley and C. D. Klaassen
Induction of Mouse UDP-Glucuronosyltransferase mRNA Expression in Liver and Intestine by Activators of Aryl-Hydrocarbon Receptor, Constitutive Androstane Receptor, Pregnane X Receptor, Peroxisome Proliferator-Activated Receptor {alpha}, and Nuclear Factor Erythroid 2-Related Factor 2
Drug Metab. Dispos., April 1, 2009; 37(4): 847 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-F. Yueh and R. H. Tukey
Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice
J. Biol. Chem., March 23, 2007; 282(12): 8749 - 8758.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Senekeo-Effenberger, S. Chen, E. Brace-Sinnokrak, J. A. Bonzo, M.-F. Yueh, U. Argikar, J. Kaeding, J. Trottier, R. P. Remmel, J. K. Ritter, et al.
Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor {alpha} Activation
Drug Metab. Dispos., March 1, 2007; 35(3): 419 - 427.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. B. Buckley and C. D. Klaassen
Tissue- and Gender-Specific mRNA Expression of UDP-Glucuronosyltransferases (UGTs) in Mice
Drug Metab. Dispos., January 1, 2007; 35(1): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Luci, H. Kluge, F. Hirche, and K. Eder
Clofibrate Increases Hepatic Triiodothyronine (T3)- and Thyroxine (T4)-Glucuronosyltransferase Activities and Lowers Plasma T3 and T4 Concentrations in Pigs
Drug Metab. Dispos., November 1, 2006; 34(11): 1887 - 1892.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
G. Werle-Schneider, A. Wolfelschneider, M. C. von Brevern, J. Scheel, T. Storck, D. Muller, R. Glockner, H. Bartsch, and M. Bartelmann
Gene Expression Profiles in Rat Liver Slices Exposed to Hepatocarcinogenic Enzyme Inducers, Peroxisome Proliferators, and 17{alpha}-Ethinylestradiol
International Journal of Toxicology, September 1, 2006; 25(5): 379 - 395.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-L. Fang, S. C. Strom, H. Cai, C. N. Falany, T. A. Kocarek, and M. Runge-Morris
Regulation of Human Hepatic Hydroxysteroid Sulfotransferase Gene Expression by the Peroxisome Proliferator-Activated Receptor {alpha} Transcription Factor
Mol. Pharmacol., April 1, 2005; 67(4): 1257 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Saeki, Y. Saito, H. Jinno, T. Tanaka-Kagawa, A. Ohno, S. Ozawa, K. Ueno, S. Kamakura, N. Kamatani, K. Komamura, et al.
SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
Drug Metab. Dispos., September 1, 2004; 32(9): 1048 - 1054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement